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Vitamin B12-dependent enzymes function in core biochemical pathways in
Mycobacterium tuberculosis, an obligate pathogen whose metabolism in vivo is
poorly understood. Although M. tuberculosis can access vitamin B12 in vitro, it
is uncertain whether the organism is able to scavenge B12 during host infection.
This question is crucial to predictions of metabolic function, but its resolution
is complicated by the absence in the M. tuberculosis genome of a direct homo-
logue of BtuFCD, the only bacterial B12 transport system described to date.
We applied genome-wide transposon mutagenesis to identify M. tuberculosis
mutants defective in their ability to use exogenous B12. A small proportion of
these mapped to Rv1314c, identifying the putative PduO-type ATP : co(I)rrinoid
adenosyltransferase as essential for B12 assimilation. Most notably, however,
insertions in Rv1819c dominated the mutant pool, revealing an unexpected func-
tion in B12 acquisition for an ATP-binding cassette (ABC)-type protein previously
investigated as the mycobacterial BacA homologue. Moreover, targeted deletion
ofRv1819c eliminated the ability ofM. tuberculosis to transport B12 and related cor-
rinoids in vitro. Our results establish an alternative to the canonical BtuCD-type
system for B12 uptake in M. tuberculosis, and elucidate a role in B12 metabolism
for an ABC protein implicated in chronic mycobacterial infection.2. Introduction
The genome of Mycobacterium tuberculosis, obligate human pathogen and causa-
tive agent of tuberculosis, encodes three B12-dependent enzymes. Previous
work in our laboratory has established that both the methylmalonyl-coenzyme
A (CoA) mutase, MutAB [1], and the metH-encoded methionine synthase [2] are
functional, and require B12 for activity. Mycobacterium tuberculosis also possesses
a predicted pathway for B12 biosynthesis [3], but appears not to produce the
cofactor in vitro [1,2] or in macrophages [4]. Nevertheless, the bacillus can use
exogenous vitamin B12 and encodes a B12-responsive riboswitch that suppresses
transcription of the alternative, B12-independent methionine synthase, metE, in
B12-replete conditions [2]. These observations imply a role for the cofactor
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Figure 1. Structure of vitamin B12 and B12-derived cofactors.
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whether B12 is available during infection, and which myco-
bacterial genes are required for its uptake and assimilation.
Vitamin B12 and B12 derivatives are members of the coba-
lamin group of corrinoid macrocycles [5]. Cobalamins are
structurally complex, comprising a defining tetrapyrrole fra-
mework with a centrally chelated cobalt ion held in place
by a lower axial base, dimethylbenzimidazole and an upper
ligand that determines the cofactor form (figure 1). The
cyano group in vitamin B12 (cyanocobalamin, CNCbl) must
be replaced by deoxyadenosine and methyl ligands, respect-
ively, during conversion to the biologically active cofactors:
adenosylcobalamin (AdoCbl or coenzyme B12), which
is required by methylmalonyl-CoA mutase, and methyl-
cobalamin (MeCbl), which serves as an intermediary in the
synthesis of methionine from homocysteine and methyltetra-
hydrofolate [6]. The reactivity of B12 cofactors derives from
the cobalt-coordinated organic ligands [7] and, together
with the size of the cobalamin core, underlies the need for
multi-component systems to mediate controlled translocation
and delivery of B12 across the cell membrane to its target
enzyme [8].
Although bioinformatic analyses have predicted alterna-
tive vitamin transporters [9], BtuCD–BtuF remains the only
confirmed bacterial B12 transport system identified to date
[10]. The Escherichia coli model is the best characterized: a
high-affinity corrinoid transporter, BtuB, operates with the
TonB–ExbBD complex to traffic B12 across the outer mem-
brane into the periplasm [11] where it is captured by the
btuF-encoded B12-binding protein and delivered to the ATP-
binding cassette (ABC) importer, BtuCD, which spans the
cytoplasmic membrane [12]. Mycobacterium tuberculosis is
characterized by a notoriously complex cell envelope com-
prising a cytoplasmic membrane and an external cell wall
[13]. However, despite its demonstrated ability to use exogen-
ous B12 [2,4], the proteins involved in mycobacterial B12
transport and assimilation are unknown: M. tuberculosis is
included in the small number of B12-using bacteria that lack
a candidate BtuFCD-type B12 transport system [3,9,14] as
well as an identifiable homologue of TonB [15].In this study, we used random mutagenesis to identify
genes whose disruption abrogated the ability of M. tuberculosis
to use exogenous vitamin B12 in vitro. Our results establish an
essential role in B12 uptake for Rv1819c, a predicted ABC
protein implicated in chronic infection in vivo [16], thereby
revealing an alternative to the well-characterized BtuCD
system for B12 transport.3. Material and methods
3.1. Bacterial strains and growth conditions
Strains, plasmids and oligonucleotides are described in the
electronic supplementary material, table S1. Mycobacterium
tuberculosis was grown on Middlebrook 7H10 (Difco) sup-
plemented with 0.5 per cent glycerol and Middlebrook
OADC enrichment (Difco) or in Middlebrook 7H9 sup-
plemented with 0.2 per cent glycerol, Middlebrook OADC
and 0.05 per cent Tween 80 or 0.05 per cent tyloxapol, as
required. For propionate utilization experiments, 7H9 broth
was supplemented with 0.5 per cent bovine serum albumin
fraction V (Sigma), 0.085 per cent NaCl and 0.1 per cent
(w/v) sodium propionate, as described [1]. Hygromycin
(hyg), kanamycin (kan) and gentamicin (gent) were used at
50, 25 and 2.5 mg ml21, respectively, CNCbl and AdoCbl
at 10 mg ml21, (CN)2Cbi at 1 mM and 3-nitropropionate (3NP)
at 0.1 mM.3.2. Construction of transposon mutant library
A library of transposon (Tn) mutants was constructed in M.
tuberculosis H37Rv DmetH, using the MycoMarT7 phage as
described [17]. For the primary screen, transductants were
plated across multiple 7H10 plates containing 20 mg ml21
kan and 10 mg ml21 CNCbl at a density of 20 000 colony
forming units (CFU) per plate. The secondary screen was per-
formed in duplicate in microtitre plate format and, for each
Tn mutant, comprised four parallel wells containing 0.1 per
cent propionate plus 20 mg ml21 kan as base medium in
each well: the first well constituted a growth control and con-
tained only the base medium; in well 2, 10 mg ml21 CNCbl
was added to the base medium; in well 3, the base medium
was supplemented with 0.1 mM 3NP; and in well 4,
0.1 mM 3NP and 10 mg ml21 CNCbl were added.3.3. Identification of transposon insertion sites
A combination of Tn-linker [18] and rescue cloning [19] strat-
egies was applied to identify Tn insertion sites using the
oligonucleotides in the electronic supplementary material,
table S1.3.4. Construction of mutant strains of Mycobacterium
tuberculosis
Mycobacterium tuberculosis mutants were constructed using
suicide plasmids described in electronic supplementary mate-
rial, table S1. Genetic complementation used tweety-based
vectors [20].
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Figure 2. Identification of genes required for B12 transport and assimilation. (a) Schematic of the screening cascade. The DmetH Tn library was plated on selective
medium containing 10 mg ml21 CNCbl. 612 ‘B12-resistant’ clones were isolated and regrown in standard liquid medium, eliminating 35 mutants owing to poor
(n ¼ 14) or absent (n ¼ 21) growth. A secondary screen tested the B12 uptake ability of the remaining 577 insertion mutants in a four-well microtitre assay
using 0.1% propionate (Prop) plus 20mg ml21 kanamycin as base medium (well 1) supplemented with 10 mg ml21 CNCbl (well 2), 3NP (well 3) and 3NP
plus 10 mg ml21 CNCbl (well 4). A total of 84 mutants failed to grow in well 4, suggesting impaired B12 uptake. Each determination was performed in duplicate,
and the results confirmed in batch culture. (b) Insertion mutants with disrupted B12 uptake ability.
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Mycobacterium tuberculosis genomic DNA was sequenced
using an Illumina GenomeAnalyzer II, as described
previously [21].
3.6. Homology modelling
The initial detection of crystal structures related to Rv1819c
was performed using HHsearch [22] and COMA [23]. The
Rv1819c model was then generated using a previously
described iterative approach [24,25]. Briefly, both the set of
structural templates and corresponding alignments were
refined until the resulting model stopped improving and
the visual inspection revealed no significant flaws.4. Results
4.1. A forward genetic screen identifies B12
uptake mutants
We showed previously that deletion of the B12-dependent
methionine synthase, MetH, renders M. tuberculosis sensitive
to vitamin B12 during growth on solid medium [2]. This phe-
notype depends on the function of a B12 riboswitch that is
located immediately upstream of metE, the gene encoding
an alternative, B12-independent methionine synthase in M.
tuberculosis. In wild-type M. tuberculosis, exogenous B12 sup-
presses transcription of metE by binding to the riboswitch
[2], possibly ensuring efficient B12-dependent methionine
synthesis by MetH. In the metH deletion mutant, however,
riboswitch-mediated suppression of metE in response to B12
effectively results in the complete shutdown of methionine
synthase activity, thereby eliminating production of anessential amino acid and so inhibiting bacillary growth [2].
This effect is most profoundly manifest on solid medium,
where exposure to 10 mg ml21 CNCbl results in a 3log10-
fold reduction in viable CFU of DmetH knockout mutants
[2]. Here, we exploited the observed B12 sensitivity of metH
mutants in a genetic screen designed to elucidate a potential
B12 transport system in M. tuberculosis (figure 2). To this
end, we constructed an unmarked metH knockout of the
laboratory strain, M. tuberculosis H37RvJO [21] (electronic
supplementary material, figure S1a) and confirmed that
it phenocopied the previously described hygromycin (hyg)-
marked DmetH (BB) deletion mutant [2] during growth on
B12-containing solid medium (see the electronic supplemen-
tary material, figure S1b). The unmarked DmetH knockout
was used as background strain in which to generate a Tn
mutant library using the MycoMarT7 phage [17] that carries
a kan resistance marker and inserts randomly at TA dinucleo-
tides [19]. In the primary screen, the library of insertion
mutants was plated on solid medium containing kan and
CNCbl to enable the identification of genes whose disruption
alleviated the growth defect of the metH mutant (figure 2a).
In total, 612 individual clones were isolated, each of which
was picked and regrown in standard liquid medium; of
these, 35 grew poorly or not at all and were eliminated, leav-
ing 577 ‘B12-resistant’ insertion mutants for further analysis.
Previously, in characterizing the DmetH (BB) mutant, we
noted the high frequency at which suppressor mutants arose
spontaneously on B12-containing solid medium, with single-
nucleotide polymorphisms (SNPs) in the B12 riboswitch located
upstream of metE accounting for approximately 10–20 per cent
of these [2]. In the current screen, we used dual selection on kan
and CNCbl in order to limit the potentially confounding effects
of spontaneous riboswitch mutations: according to these
criteria, growth on CNCbl plus kan would require successful
transduction with the kan-resistant Tn as well as disruption—
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Figure 3. Disruption of Rv1819c eliminates the ability of M. tuberculosis DmetH to use corrinoids for growth in 0.1% propionate-containing 3NP. Data are from a
representative experiment performed in duplicate.
rsob.royalsocietypublishing.org
Open
Biol3:120175
4
 on September 12, 2018http://rsob.royalsocietypublishing.org/Downloaded from spontaneous or Tn-mediated—of B12-dependent growth
inhibition. Nevertheless, we predicted that a significant pro-
portion of B12-resistant mutants might contain Tn insertions
in the riboswitch motif. So, in order to minimize the impact of
disruptions to the B12 riboswitch, we applied a secondary
screen (figure 2a) to determine the capacity of the insertion
mutants to assimilate exogenous CNCbl for growth in liquid
medium containing propionate in the presence of 3NP, an
inhibitor of the key methylcitrate cycle enzyme, isocitrate
lyase [26]. Two prior observations informed the design of this
screen: (i) the inhibitory effect of genetic (DprpDC) or chemical
(3NP) abrogation of methylcitrate cycle enzymes during
growth in liquid medium containing propionate can be alle-
viated by supplementing the culture with CNCbl, thereby
enabling M. tuberculosis to use propionate as a carbon source
via the methylmalonyl pathway that includes the B12-depen-
dent methylmalonyl-CoA mutase, MutAB [1]; (ii) for reasons
that are not clear, B12-mediated growth inhibition is less effec-
tive in liquid versus solid medium—that is, the DmetH mutant
can grow in B12-supplemented liquid medium (see the electronic
supplementary material, figure S1c).
The secondary screen therefore assessed the ability of
all 577 Tn mutants to use exogenous CNCbl for growth in
liquid medium containing propionate in the presence of 3NP
(figure 2a). The majority of Tn mutants (n ¼ 493) phenocopied
the parental DmetH strain in this assay, and were eliminated as
candidate B12 uptake mutants. In contrast, the remaining 84 Tn
mutants were unable to grow in well 4, suggesting impaired
ability to use exogenous B12 for methylmalonyl pathway-
dependent propionate catabolism. To verify these results,
43 of the 84 mutants were selected at random for phenotypic
confirmation of disrupted B12 uptake in batch culture (data
not shown) and on B12-containing solid medium (see the
electronic supplementary material, figure S2a).4.2. Disruption of Rv1819c eliminates the ability
of Mycobacterium tuberculosis to use exogenous
B12 in vitro
Insertions in Rv1819c accounted for 72 of the 84 Tn
mutants (figure 2b; electronic supplementary material,figure S2a–c) and, moreover, mapped throughout the
1920 bp gene (electronic supplementary material, figure
S2d ). This result strongly suggested a role in B12 uptake for
a predicted ABC transport protein previously identified as
the putative M. tuberculosis homologue of BacA [16,27], a
protein of cryptic function implicated in chronic infection in
multiple host–pathogen models [25]. In their study of
M. tuberculosis Rv1819c, Domenech et al. [16] constructed a
deletion mutant by allelic exchange mutagenesis (see the
electronic supplementary material, figure S2b). We assessed
the ability of this mutant—referred to as DbacA::hyg by
Domenech et al. [16]—to use exogenous B12 for MutAB-
dependent growth in propionate (electronic supplementary
material, figure S3a). Consistent with the inferred role of
Rv1819c in B12 uptake, the DbacA::hyg strain grew very
poorly in propionate plus 3NP supplemented with B12, repro-
ducing the phenotype of the DmetH Rv1819c::Tn mutants
(figure 3). By contrast, the complemented derivative carrying
a full-length copy of Rv1819c at the attB site, referred to as
DbacA::pKLMt5 in the original study [16], was able to use
B12 for growth (see the electronic supplementary material,
figure S3a). Similarly, integration of full-length Rv1819c
at attB restored the B12-sensitive phenotype of a randomly
selected DmetH Rv1819c::Tn mutant during growth on
solid medium supplemented with CNCbl (see the electronic
supplementary material, figure S3b), and reversed the
inability of the same mutant to use B12 for growth in propio-
nate-containing liquid medium supplemented with 3NP
(figure 3), confirming the essentiality of Rv1819c in this assay.
It was noticeable in the propionate utilization experiment
(see the electronic supplementary material, figure S3a) that
the DbacA::hyg mutant started to replicate after two to three
weeks of apparent growth arrest, possibly indicating the
emergence of suppressor mutants. To circumvent this com-
plication, we deleted the prpDC locus [28] in this strain,
thereby negating the need to use 3NP to eliminate methylcitrate
pathway function [1]. In contrast to the single prpDC deletion
mutant, the double DbacA::hyg DprpDC knockout exhibited no
growth at all in propionate over the 28-day time course (see
the electronic supplementary material, figure S3c), even when
supplemented with CNCbl, strongly suggesting that Rv1819c
is required for the assimilation of exogenous B12 to enable
methylmalonyl-CoA pathway function.
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non-synonymous single-nucleotide
polymorphisms in Rv1819c
We reported previously that SNPs in the metE-associated B12
riboswitch accounted for 10–20 per cent of all B12-resistant
mutants isolated after plating the DmetH (BB) knockout on
medium containing CNCbl, whereas the remaining B12-resist-
ance mutations were unknown [2]. To investigate the
possibility that mutations in Rv1819c might account for B12
resistance in those clones lacking riboswitch mutations, we
plated the DmetH (BB) strain on medium containing CNCbl
and sequenced the riboswitch region and Rv1819c locus in 10
spontaneous B12-resistant mutants. Consistent with previous
results [2], two isolates carried independent mutations in the
highly conserved B12-box motif within the metE riboswitch
[29], namely C! T transversions at positions 2155 and
2163 relative to the metE start codon, respectively. Notably,
four other B12-resistant mutants had wild-type riboswitch
sequences, but contained non-synonymous SNPs in Rv1819c
(see the electronic supplementary material, table S2), support-
ing the inferred role of Rv1819c in B12 uptake. To eliminate the
possibility that an additional, unidentified mutation (or
mutations) might account for the observed phenotype, we
sequenced the genome of a representative Rv1819c point
mutant, SP09 (see the electronic supplementary material,
table S2). The parental, B12-sensitive strain, DmetH (BB), was
differentiated from the laboratory strain, H37RvJO [21], only
in the targeted deletion of metH sequence. Moreover, the
Rv1819c mutation constituted the sole polymorphism separ-
ating SP09 from its DmetH (BB) parent and, importantly,
complementation with wild-type Rv1819c at the attB locus
restored B12 sensitivity to both SP09 and SP18 (see the
electronic supplementary material, figure S4).
In the primary Tn screen (figure 2a), ‘B12-resistant’
mutants had been selected on kan and CNCbl in order to
limit the potentially confounding effects of spontaneous
riboswitch mutations. To verify the utility of this approach,
we analysed the insertion sites in a random selection of
20 of the 493 DmetH Tn mutants subsequently eliminated in
the secondary screen owing to their inability to use exogen-
ous B12 for growth in propionate. All 20 mutants contained
insertions in the B12 riboswitch region directly upstream of
metE (data not shown), confirming that disrupted riboswitch
function represents a major mechanism for loss of B12
regulation in strains which carry an intact Rv1819c gene.4.4. Rv1819c is essential for corrinoid transport in
Mycobacterium tuberculosis
Mycobacterium tuberculosis is predicted to encode a complete
pathway for B12 biosynthesis, including enzymes required
for the conversion of the B12 precursor, cobinamide, to
AdoCbl through the addition of dimethylbenzimidazole
and deoxyadenosine ligands [3]. The E. coli corrinoid trans-
porter, BtuFCD, mediates uptake of cobinamide as well as
CNCbl and AdoCbl [30], suggesting that Rv1819c might
fulfil a corresponding role in M. tuberculosis. In support of
this idea, cobinamide—provided as the dicyanide salt,
(CN)2Cbi—was unable to complement the growth defect of
DmetH Rv1819c::Tn mutants in propionate in the presenceof 3NP, mimicking similar observations with AdoCbl and
CNCbl (figure 3). Insertions in Rv1819c also alleviated the
growth inhibitory effect of AdoCbl, CNCbl and (CN)2Cbi on
the metH knockout mutant on solid medium, a phenotype
that was reversed upon complementation with wild-type
Rv1819c (see the electronic supplementary material, figure S5).
In combination, these results confirmed the essentiality of
Rv1819c for corrinoid transport in M. tuberculosis.
4.5. Impaired vitamin B12 uptake in spontaneous
bleomycin-resistant Rv1819c mutants
Domenech et al. [16] showed that deletion of Rv1819c decrea-
sed the susceptibility of M. tuberculosis to the glycopeptide
antibiotic, bleomycin, a phenotype commonly associated with
BacA function [31–33]. We determined the minimum inhibitory
concentration (MIC) of bleomycin against a selected Rv1819c::Tn
mutant (electronic supplementary material, figure S6a) as well as
the spontaneous B12-resistant mutants, SP09 and SP18 (see the
electronic supplementary material, figure S6b), and observed
values comparable to that reported for DbacA::hyg [16]. To
explore further the overlap between B12 uptake and bleomycin
susceptibility, we isolated spontaneous bleomycin-resistant
(BleoR) mutants in two different genetic backgrounds, DprpDC
and the unmarked metH knockout, by plating the strains on
solid medium containing 3 mg ml21 bleomycin (10 MIC).
Five BleoR mutants each of the DprpDC and DmetH knockouts
were selected at random, and shown to be defective in their abil-
ity to use B12 for MutAB-dependent growth in propionate (see
the electronic supplementary material, figure S7a). Moreover,
the spontaneous BleoR mutants of DmetH were resistant to
CNCbl during growth on solid medium (see the electronic
supplementary material, figure S7b). All five BleoR mutants
derived from the DprpDC strain carried nonsense mutations in
Rv1819c, whereas missense mutations in Rv1819c were ident-
ified in four of five spontaneous BleoR DmetH mutants (see the
electronic supplementary material, table S2). Moreover, comple-
mentation with full-length Rv1819c reversed the inability of the
spontaneous Rv1819c point mutants of DprpDC to catabolize
propionate in liquid medium supplemented with CNCbl
(figure 4), and restored the bleomycin susceptibility of
SP09 to wild-type levels (see the electronic supplementary
material, figure S6c).
4.6. Rv1819c encodes an ATP-binding cassette-type
transporter
Rv1819c was previously included in a group of ‘BacA-related’
proteins identified on the basis of their similarity to the highly
conserved BacA and SbmA proteins of Sinorhizobium and
E. coli, respectively [27]. Unlike BacA/SbmA orthologues,
however, which are predicted to require an interaction with a
separate cytoplasmic protein for function, Rv1819c encodes
both transmembrane (TMD) and nucleotide-binding (NBD)
domains of an ABC transport protein on a single polypeptide.
Sequence similarity analyses using only the TMD located
M. tuberculosis Rv1819c in a cluster distinct from BacA/SbmA
(see the electronic supplementary material, figure S8a). More-
over, these analyses indicated that Rv1819c was more closely
related to ABC proteins other than BacA/SbmA in both E.
coli and Sinorhizobium, namely YddA [34] and ExsE [35],
respectively. The Rv1819c NBD similarly identified YddA
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Figure 4. Impaired B12 uptake in a spontaneous bleomycin-resistant (Bleo
R)
prpDC mutant, PBSP04, carrying a SNP in Rv1819c (see the electronic sup-
plementary material, table S2). Strains were grown in 0.1% propionate
supplemented with 3NP and CNCbl. Data are from a representative exper-
iment performed in duplicate.
Sav1866 Rv1819c
L442
G411
P349
Figure 5. Rv1819c encodes an ABC-type transporter. Computational model of
M. tuberculosis Rv1819c (amino acid residues 66–639) compared with the
x-ray structure of Staphylococcus aureus Sav1866 (PDB code: 2HYD) [37].
The model is based on the crystal structures of Sav1866 and the ABC lipid
flippase, MsbA, from Salmonella typhimurium (PDB code: 3B60) [38], both
of which contain transmembrane- (green) and nucleotide-binding (blue)
domains fused into a single polypeptide chain that interacts to form a homo-
dimer in the active protein. The two subunits in both structures are denoted
by the different colour intensities. ADP molecules bound to each subunit are
shown in purple and light purple, respectively. Residues substituted in spon-
taneous Rv1819c mutants are indicated with red arrows.
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search (see the electronic supplementary material, figure S8b),
together with the recently described human ABC-type B12
transporter, ABCD4 [36].
We built a homology model of Rv1819c based on
the crystal structures of two polyspecific ABC exporters,
Staphylococcus aureus Sav1866 [37] and Salmonella typhimurium
MsbA [38]. Consistent with known ABC protein architecture
[39], Rv1819c is predicted to form a homodimer (figure 5),
with each subunit comprising an N-terminal TMD fused to a
highly conserved NBD that features all the motifs characteristic
of functional ABC transporters (see the electronic supple-
mentary material, figure S9a). Unlike Sav1866 and MsbA,
though, the TMD domain of Rv1819c possesses an extra
N-terminal region which is predicted to contain an additio-
nal transmembrane helix (see the electronic supplementary
material, figure S9b). Proteomic analyses in the closely related
M. bovis BCG suggest that this region is present in the mature
protein [40], and therefore is not a signal peptide. However,
in the absence of a close structural template containing seven
transmembrane helices, we omitted the first 65 N-terminal resi-
dues in building the Rv1819c model. The predicted structure
nevertheless provides a useful framework for the interpretation
of experimental data. Notably, all three SNPs which resulted in
substituted amino acids in the spontaneous B12-resistant and
BleoR mutants (see the electronic supplementary material,
table S2) affect residues located in conserved regions of
Rv1819c (figure 5). While the structural consequences of the
P349T and G411D mutations require further investigation,
L442S affects a conserved position in the putative nucleotide-
binding pocket formed by two interacting ABC domains. In
Sav1866, the corresponding residue, Ile356, makes a van der
Waals contact with the sugar moiety of the bound ADP [37],
and so supports the inferred association between a distorted
pocket and crippled protein function.4.7. A PduO-type adenosyltransferase is required for
assimilation of vitamin B12
CNCbl must be adenosylated to generate the active cofactor,
AdoCbl [41] (figure 6a). The genome of M. tuberculosis is pre-
dicted to encode both CobO (Rv2849c) and PduO (Rv1314c)
ATP:co(I)rrinoid adenosyltransferases [3], non-homologous
enzymes that catalyse this reaction in other bacteria [42,43].
It was notable, therefore, that six putative B12 uptake mutants
(figure 2) contained Tn insertions in pduO (see the electronic
supplementary material, figure S2d ), because this suggested
that an impaired ability to convert exogenous CNCbl to the
cofactor form could confer B12 resistance in the primary
screen, as well as eliminate the ability of M. tuberculosis to use
B12 for growth in propionate. To confirm the role of PduO-
dependent adenosylation in these phenotypes, we evaluated
the abilities of theDmetH pduO::Tn mutants to assimilate differ-
ent corrinoids for growth in propionate in the presence of 3NP
(figure 6b). The mutants were unable to use either cyano form,
CNCbl or (CN)2Cbi, both of which are adenosylated in the
biosynthetic pathway to AdoCbl (figure 6a). In contrast, sup-
plementation with AdoCbl itself restored growth in this
assay (figure 6b), suggesting bypass of PduO function. In com-
bination, these observations implicate PduO as sole active
adenosyltransferase in M. tuberculosis during growth in vitro.5. Discussion
Our results identify Rv1819c as sole corrinoid transporter in
M. tuberculosis under standard in vitro conditions and, more-
over, establish the capacity of the organism to scavenge
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Figure 6. PduO is essential for B12 salvage and assimilation. (a) Predicted steps in late-stage AdoCbl biosynthesis and salvage in M. tuberculosis. Cobinamide is
provided in vitro as a dicyanide salt, (CN)2Cbi. (b) The DmetH pduO::Tn mutant cannot use CNCbl or (CN)2Cbi for growth in 0.1% propionate-containing 3NP. Data
are from a representative experiment performed in duplicate.
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unexpected, particularly given previous studies suggesting
that Rv1819c might function in ATP-dependent peptide
transport [16,44]. Moreover, the properties enabling polyspe-
cific translocation of compounds such as bleomycin, B12 and
antimicrobial peptides which lack obvious structural simi-
larity remain unclear [45]. In Gram-positive organisms,
ABC-mediated importers function together with a high-affi-
nity substrate-binding protein (SBP) that is anchored to the
extracytoplasmic membrane [46]. Although M. tuberculosis
possesses in excess of 30 ABC transporters, as well as 15 puta-
tive SBPs [47], we failed to identify a candidate B12-binding
protein, raising the possibility that Rv1819c-mediated B12
import occurs in the absence of a specific SBP or that multiple
proteins fulfil this role [48]. In most bacteria, the components
of the ABC transporters involved in the uptake of ferric side-
rophores, haem and vitamin B12 are closely related [49].
However, our screen identified Rv1819c as sole transport
candidate, excluding the possibility that other ABC proteins
might perform overlapping functions in mycobacterial B12
transport, at least under in vitro conditions. Instead, in associ-
ating Rv1819c with B12 uptake, our results add to the
expanding complement of atypical mycobacterial nutrient
acquisition systems. For example, a novel pathway was
recently elucidated that enables the scavenging of haem
[50]—a tetrapyrrole which, like B12, is derived from d-amino-
laevulinic acid via a uroporphyrinogen III intermediate [5].
In that system, uptake is mediated by the combined activity
of a haem-binding protein and the MmpL family members
MmpL3 and MmpL11—predicted RND-type efflux pumps
which have been associated with multiple cellular functions
[51]. In addition to haem import, recent evidence suggests
that MmpL3 fulfils an essential role in exporting trehalose
monomycolate across the cell membrane for incorporation
into cell wall mycolic acids [52,53], and it has also been impli-
cated in the susceptibility of M. tuberculosis to diverse small
molecules [54,55]. It is tempting, therefore, to consider the
analogy with Rv1819c—itself a predicted export protein
that has now been implicated in the uptake of antimicrobial
peptides [16,44] and vitamin B12, and might also play a role
in cell wall biogenesis [16].
Rv1819c has been extensively investigated as M. tuberculosis
BacA [16,44]. Unlike BacA/SbmA orthologues, however,
deletion of Rv1819c does not render M. tuberculosishypersusceptible to other antimicrobial drugs and cell dis-
rupting agents [16]. Moreover, our structural model of
M. tuberculosis Rv1819c predicts an ABC transporter compris-
ing both TMD and NBD within a single polypeptide. This
distinguishes the mycobacterial protein from BacA proteins in
Brucella and other intracellular pathogens [32] that contain the
TMD only and, importantly, is supported by sequence analyses
that situate Rv1819c in a separate cluster from the BacA sub-
family even when based on TMD sequence alone. The
M. tuberculosis protein also differs from BacA proteins in its
potential role in pathogenesis. While the essentiality of the
mycobacterial protein for the maintenance of chronic infection
in vivo [16] is reminiscent of BacA-like phenotype, closer inspec-
tion of the comparative in vivo infection dynamics of different
‘bacA’ mutants suggests divergent function: for example, in con-
trast to the Brucella and Sinorhizobium deletion mutants [27,32],
the M. tuberculosis Rv1819c knockout is not impaired in its
ability to establish an infection [16]. It is tempting, therefore,
to consider the virulence defect of the Rv1819c deletion
mutant in the light of recent studies describing the accumu-
lation during chronic infection of cholesterol-rich lipid bodies
inside foamy macrophages and their infecting bacilli [56,57].
That is, Rv1819c might function to ensure adequate supply of
host-derived corrinoids for the B12-dependent utilization of
propionate derived from cholesterol catabolism, a possibility
that requires further investigation.
Although designed to detect a putative vitamin B12
transporter, our screen also established the essentiality of
the PduO-type adenosyltransferase for the assimilation
of exogenous corrinoids. The M. tuberculosis genome contains
both pduO and cobO adenosyltransferases; therefore, the
inferred inactivity of the alternative enzyme in vitro might
indicate functional adaptation of CobO to de novo B12
biosynthesis [3], or to specific environmental conditions,
including anaerobiosis [41]. Intracellular trafficking of B12 in
humans requires the sequential activity of multiple proteins
which fulfil dual roles as molecular chaperones and in the
enzymatic modification of the cofactor [58]. For example,
MMACHC catalyses the reductive decyanation of CNCbl
[59] while mediating LMBD1-dependent [60] transfer from
the lysosome into the cytoplasm. Recent evidence further
suggests that this process is facilitated by the interaction of
LMBD1 with ABCD4 [36]—an ABC transporter and homo-
logue of Rv1819c (see the electronic supplementary material,
rsob.royalsocietypublishing.org
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transferase attaches the axial ligand and ensures delivery of
the resulting AdoCbl cofactor across the mitochondrial mem-
brane to its target enzyme, methylmalonyl-CoA mutase [61].
Given that Tn-mediated disruption of pduO alleviated the
B12 sensitivity of the metH mutant in the primary screen, it is
tempting to speculate that PduO might function not merely
in enzymatic conversion of exogenous corrinoids, but also in
delivery of the active cofactor into the cytoplasm. Our current
model for the translocation of B12 across the mycobacterial cell
wall into the cytoplasm therefore proposes the sequential
activity of the ABC transporter, Rv1819c and the PduO-type
adenosyltransferase (figure 6a).
Our Tn screen also identified four low-frequency inser-
tions associated with compromised B12 uptake (figure 2b).
Targeted sequencing of Rv1819c and the metE riboswitch in
these strains excluded spontaneous mutations as the under-
lying cause of the observed B12 phenotypes. A single
mutant carried an insertion in rpfB, which encodes a resusci-
tation-promoting factor. To explore this result further, we
retested DmetH rpfB::Tn in parallel with an rpfB deletion
mutant of H37Rv, constructed previously [62]. Although
the Tn mutant was not able to use exogenous CNCbl for
growth in propionate-containing medium, the DrpfB knock-
out strain phenocopied wild-type H37Rv in this assay (data
not shown), thereby excluding a role for RpfB in B12
uptake. It is possible that rpfB::Tn possesses an additional,
unidentified polymorphism, affecting B12 assimilation; alter-
natively, polar effects on the downstream gene, ksgA,
encoding dimethyladenosine transferase, might contribute
to the observed phenotype [63], a possibility under investi-
gation. Two additional Tn insertions mapped to mymA,
encoding a putative flavin-dependent monooxygenase. The
predicted role of MymA in the maintenance of cell wall ultra-
structure [64] suggests that compromised B12 uptake in thesemutants might be non-specific; however, this requires further
investigation, and is complicated by the fact that mymA is the
first gene in a seven-gene operon [65]. We also isolated a
mutA::Tn mutant, whose inability to use propionate for
growth in B12-containing medium is consistent with impaired
methylmalonyl-CoA mutase function. The basis for the B12
resistance of this mutant in the primary screen is unclear,
however, and probably also the result of an additional spon-
taneous mutation. The final Tn insertion mapped to Rv2927c,
a gene which previous saturation mutagenesis studies have
predicted as essential for growth of M. tuberculosis in vitro
[66,67]. Although the function of Rv2927c is unknown, it has
been proposed to operate as part of the cell division machinery
[68]. It seems probable that, like the mymA::Tn mutants, the
failure of Rv2927c::Tn to assimilate B12 is non-specific. How-
ever, given the inferred requirement for PduO-dependent
adenosylation in the assimilation of exogenous B12, the predic-
tion that Rv2927c might function in de novo adenosine
nucleotide biosynthesis [69] is intriguing, and the subject of
current investigation.6. Acknowledgements
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